Increased expression of WNK3 in dispersed granule cells in hippocampal sclerosis of mesial temporal lobe epilepsy patients

Epilepsy Res. 2018 Nov:147:58-61. doi: 10.1016/j.eplepsyres.2018.09.006. Epub 2018 Sep 17.

Abstract

Granule cell dispersion (GCD) is a common neuropathological feature of hippocampal sclerosis (HS) in patients with temporal lobe epilepsy (TLE). However, the underlying molecular mechanism of GCD formation remains unclear. The present study aimed to investigate the expressional changes of With No Lysine protein kinase subtype 3 (WNK3), a molecule upstream of cation-chloride cotransporters with reciprocal expression in sclerosed hippocampus of TLE patients. Using immunofluorescence staining, we analyzed WNK3 immunoreactivity in hippocampal specimens from histologically normal controls and TLE patients with HS. Our results showed that WNK3 expression was significantly increased in dispersed granule neurons in hippocampal tissues from patients with TLE compared with histologically normal hippocampus. These findings demonstrate a potential association between an increased expression of WNK3 and GCD formation during the chronic phase of epilepsy. Controlling WNK3 expression may thus be a novel therapeutic target in epileptogenesis.

Keywords: Granule cell dispersion; Hippocampal sclerosis; Temporal lobe epilepsy; WNK3.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Child
  • Child, Preschool
  • Epilepsy, Temporal Lobe / complications
  • Epilepsy, Temporal Lobe / pathology*
  • Female
  • Hippocampus / pathology*
  • Humans
  • Male
  • Middle Aged
  • Neurons / metabolism*
  • Phosphopyruvate Hydratase / metabolism
  • Protein Serine-Threonine Kinases / metabolism*
  • Sclerosis / etiology
  • Sclerosis / pathology
  • Statistics, Nonparametric
  • Up-Regulation / physiology*
  • Young Adult

Substances

  • Protein Serine-Threonine Kinases
  • WNK3 protein, human
  • Phosphopyruvate Hydratase